Advertisement
Advertisement
SGMT
Sagimet Biosciences Inc. Series A Common Stock
7.00
USDSponsored
+0.08
+1.08%
Jun 25, 09:47 UTC -4
Open
SGMT Earnings Reports
Positive Surprise Ratio
SGMT beat 8 of 12 last estimates.
67%
Next Report
Date of Next Report
Aug 17, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.25
Implied change from Q1 26 (Revenue/ EPS)
--
/-24.24%
Implied change from Q2 25 (Revenue/ EPS)
--
/-21.88%
Sagimet Biosciences Inc. Series A Common Stock earnings per share and revenue
On May 12, 2026, SGMT reported earnings of -0.33 USD per share (EPS) for Q1 26, beating the estimate of -0.38 USD, resulting in a 13.57% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.52% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.25 USD, with revenue projected to reach -- USD, implying an decrease of -24.24% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
What were Sagimet Biosciences Inc. Series A Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Sagimet Biosciences Inc. Series A Common Stock reported EPS of -$0.33, beating estimates by 13.57%, and revenue of $0.00, 0% as expectations.
How did the market react to Sagimet Biosciences Inc. Series A Common Stock's Q1 2026 earnings?
The stock price moved down -0.52%, changed from $7.69 before the earnings release to $7.65 the day after.
When is Sagimet Biosciences Inc. Series A Common Stock expected to report next?
The next earning report is scheduled for Aug 17, 2026.
What are the forecasts for Sagimet Biosciences Inc. Series A Common Stock's next earnings report?
Based on --
analysts, Sagimet Biosciences Inc. Series A Common Stock is expected to report EPS of -$0.25 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement